Found 10 matching trials
Assess Incidence of Deep Vein Thrombosis(DVT)Following Administration of Recombinant Human Antithrombin (rhAT) to Hereditary Antithrombin(AT) Deficient Patients in High Risk Situations. PHASE3 Patients with hereditary antithrombin (AT) deficiency are at increased risk...
Show More Location
Multiple Locations
Learn More & Join Trial
Response of Continuous Recombinant Antithrombin Infusion in Postcardiotomy ECMO Patients EARLY_PHASE1 The objective of this study will be to prospectively evaluate the response ...
Show More Location
Multiple Locations
Learn More & Join Trial
Recombinant Human Antithrombin (rhAT) in Patients With Hereditary Antithrombin Deficiency Undergoing Surgery or Delivery PHASE3 Patients with hereditary antithrombin deficiency are at increased risk of v...
Show More Location
Multiple Locations
Learn More & Join Trial
Combined Drug Approach to Prevent Ischemia-reperfusion Injury During Transplantation of Livers (CAPITL) PHASE2 The purpose of this study is to establish the effectiveness of the combined...
Show More Location
University Hospitals Leuven
Learn More & Join Trial
Pharmacokinetic Study of Recombinant AT III in Neonates Undergoing ECMO PHASE4 Maintenance of adequate anticoagulation or blood thinning is of critical im...
Show More Location
Children's Hospital Los Angeles
Learn More & Join Trial
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia PHASE3 The purpose of the study is to assess the efficacy, safety and pharmacokine...
Show More Location
University of Alabama
Learn More & Join Trial
Understanding "Heparin Resistance" in Cardiac Surgery PHASE1 This study will explore altered heparin responsiveness (AHR) in cardiac sur...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
Antithrombin III Supplementation for Cardiopulmonary Bypass in Neonates PHASE1 A prospective, randomized, placebo-controlled, double-blinded pilot study i...
Show More Location
Children's Hospital of Wisconsin
Learn More & Join Trial
Response of Recombinant Antithrombin in Heparin Resistant Patients Undergoing Cardiac Surgery PHASE4 The objective of this study is to prospectively evaluate the response of re...
Show More Location
Mayo Clinic in Rochester
Learn More & Join Trial
Recombinant Human Antithrombin (ATryn®) in the Treatment of Patients With DIC Associated With Severe Sepsis PHASE2 The primary objective of the study is to explore the efficacy and safety of...
Show More Location
Multiple Locations
Learn More & Join Trial